Team Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-31
Closed -$6.74K 57
2026
Q1
$6.74K Hold
31
﹤0.01% 208
2025
Q4
$7.08K Hold
31
﹤0.01% 200
2025
Q3
$7.18K Hold
31
﹤0.01% 198
2025
Q2
$5.75K Buy
+31
New +$5.76K ﹤0.01% 196
2023
Q4
Sell
-38
Closed -$5.66K 222
2023
Q3
$5.66K Buy
+38
New +$5.58K ﹤0.01% 136

Other funds holding ABBV

Team Financial Group's ABBV Position: Q2 2026 in Review

Team Financial Group sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 31 shares — an estimated $6.74K sold.

Team Financial Group first reported a position in ABBV in Q3 2023 and held it in 5 quarters. The position peaked at $7.18K in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Team Financial Group reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Team Financial Group sold 31 AbbVie shares in Q2 2026, an estimated $6.74K.
  • Team Financial Group first reported a position in AbbVie in Q3 2023 and held it in 5 quarters.
  • Team Financial Group's AbbVie position peaked at $7.18K in Q3 2025.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Team Financial Group's 13F filing for Q2 2026, filed 13 Jul 2026.